Bortezomib Maintenance in High Risk DLBCL

NCT01965977 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: Bortezomib

Sponsor

Samsung Medical Center

Collaborators

[object Object]